HRMY
HEALTHCAREHarmony Biosciences Holdings
AI Insight
What's Moving HRMY Today?
No stock-specific AI insight has been generated for HRMY yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$25.52$40.87
$34.16
Fundamentals
Market Cap$1.9B
P/E Ratio13.5
EPS$2.48
Dividend Yield—
Dividend / Share—
ROE17.9%
Profit Margin16.2%
Debt / Equity—
Trading
Volume468K
Avg Volume (10D)—
Shares Outstanding57.9M
HRMY News
23 articles- Harmony Biosciences Stock - Analyst consensus and technical backdropAD HOC NEWS·Jun 20, 2026
- Harmony Biosciences (HRMY) Stock Valuation After New Pitolisant Data And Reaffirmed GuidanceYahoo Finance·Jun 12, 2026
- Paragon Advances Registration-Ready CNS Asset Addressing Important Unmet Need and Closes Sale to Teva PharmaceuticalYahoo Finance·Jun 11, 2026
- Is Harmony Biosciences Holdings, Inc. (HRMY) A Good Stock To Buy Now?Yahoo Finance·Jun 11, 2026
- Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual MeetingYahoo Finance·Jun 11, 2026
- Looking Back at Stock Picks Hyatt Hotels, Sensient Technologies, Harmony Biosciences. What the Charts Say.Yahoo Finance·Jun 4, 2026
- Harmony Biosciences Holdings (HRMY): One of the Best Stocks to Buy According to AIYahoo Finance·Jun 1, 2026
- Harmony Biosciences to Participate in Upcoming Investor ConferencesYahoo Finance·May 27, 2026
- A beaten-down biotech just lost a meaningful backer — should you care?Motley Fool·May 19, 2026
- Investors Can Find Comfort In Harmony Biosciences Holdings' (NASDAQ:HRMY) Earnings QualityYahoo Finance·May 14, 2026
- Harmony Biosciences Holdings (HRMY) Announces Financial Results for Q1 2026Yahoo Finance·May 12, 2026
- Earnings Miss: Harmony Biosciences Holdings, Inc. Missed EPS By 21% And Analysts Are Revising Their ForecastsYahoo Finance·May 11, 2026
- ANIP Q1 Earnings & Sales Beat Estimates, '26 Outlook RaisedYahoo Finance·May 11, 2026
- Harmony Biosciences Holdings (HRMY) Valuation After Q1 2026 Earnings Miss And Profitability ConcernsYahoo Finance·May 9, 2026
- Is Harmony Biosciences Holdings, Inc. (HRMY) One of The Best Small Cap Value Stocks to Buy?Insider Monkey·May 9, 2026
- Should Harmony Biosciences’ Softer Q1 2026 Earnings and Upbeat Forecasts Require Action From HRMY Investors?Yahoo Finance·May 8, 2026
- Harmony Biosciences Q1 Earnings Call HighlightsMarketbeat·May 8, 2026
- Sector Update: Health Care Stocks Softer Late AfternoonYahoo Finance·May 7, 2026
- Harmony Biosciences (NASDAQ: HRMY) grows Q1 sales 17% and reaffirms $1B 2026 guidanceStock Titan·May 7, 2026
- Harmony Biosciences Holdings, Inc. (HRMY) Q1 Earnings and Revenues Miss EstimatesYahoo Finance·May 7, 2026
- Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic PrioritiesYahoo Finance·May 7, 2026
- Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass EstimatesYahoo Finance·May 6, 2026
- 12 Small-Cap Stocks Primed for Breakouts as Earnings ApproachInvesting.com·Apr 16, 2026
All 23 articles loaded
Price Data
Open$33.67
Previous Close$34.16
Day High$34.31
Day Low$33.44
52 Week High$40.87
52 Week Low$25.52
52-Week Range
$25.52$40.87
$34.16
Fundamentals
Market Cap$1.9B
P/E Ratio13.5
EPS$2.48
Dividend Yield—
Dividend / Share—
ROE17.9%
Profit Margin16.2%
Debt / Equity—
Trading
Volume468K
Avg Volume (10D)—
Shares Outstanding57.9M
About Harmony Biosciences Holdings
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—